These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 29735936)
1. Experimental Intrastriatal Applications of Botulinum Neurotoxin-A: A Review. Hawlitschka A; Wree A Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735936 [TBL] [Abstract][Full Text] [Related]
2. Repeated intrastriatal application of botulinum neurotoxin-A did not influence choline acetyltransferase-immunoreactive interneurons in hemiparkinsonian rat brain - A histological, stereological and correlational analysis. Hawlitschka A; Berg C; Schmitt O; Holzmann C; Wree A; Antipova V Brain Res; 2020 Sep; 1742():146877. PubMed ID: 32387181 [TBL] [Abstract][Full Text] [Related]
3. Intrastriatal injection of botulinum neurotoxin-A is not cytotoxic in rat brain - A histological and stereological analysis. Mehlan J; Brosig H; Schmitt O; Mix E; Wree A; Hawlitschka A Brain Res; 2016 Jan; 1630():18-24. PubMed ID: 26562665 [TBL] [Abstract][Full Text] [Related]
4. Behavioral and structural effects of unilateral intrastriatal injections of botulinum neurotoxin a in the rat model of Parkinson's disease. Antipova V; Hawlitschka A; Mix E; Schmitt O; Dräger D; Benecke R; Wree A J Neurosci Res; 2013 Jun; 91(6):838-47. PubMed ID: 23553727 [TBL] [Abstract][Full Text] [Related]
5. Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease. Wree A; Mix E; Hawlitschka A; Antipova V; Witt M; Schmitt O; Benecke R Neurobiol Dis; 2011 Feb; 41(2):291-8. PubMed ID: 20955797 [TBL] [Abstract][Full Text] [Related]
6. Effects of intrastriatal botulinum neurotoxin A on the behavior of Wistar rats. Holzmann C; Dräger D; Mix E; Hawlitschka A; Antipova V; Benecke R; Wree A Behav Brain Res; 2012 Sep; 234(1):107-16. PubMed ID: 22728288 [TBL] [Abstract][Full Text] [Related]
8. Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior. Antipova VA; Holzmann C; Schmitt O; Wree A; Hawlitschka A Front Behav Neurosci; 2017; 11():119. PubMed ID: 28680396 [TBL] [Abstract][Full Text] [Related]
9. Repeated Intrastriatal Botulinum Neurotoxin-A Injection in Hemiparkinsonian Rats Increased the Beneficial Effect on Rotational Behavior. Hawlitschka A; Holzmann C; Wree A; Antipova V Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208596 [TBL] [Abstract][Full Text] [Related]
10. Dopamine, Noradrenaline and Serotonin Receptor Densities in the Striatum of Hemiparkinsonian Rats following Botulinum Neurotoxin-A Injection. Mann T; Zilles K; Dikow H; Hellfritsch A; Cremer M; Piel M; Rösch F; Hawlitschka A; Schmitt O; Wree A Neuroscience; 2018 Mar; 374():187-204. PubMed ID: 29421436 [TBL] [Abstract][Full Text] [Related]
11. Intrastriatal administration of botulinum neurotoxin A normalizes striatal D Wedekind F; Oskamp A; Lang M; Hawlitschka A; Zilles K; Wree A; Bauer A J Neurosci Res; 2018 Jan; 96(1):75-86. PubMed ID: 28695985 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease. Antipova V; Holzmann C; Hawlitschka A; Witt M; Wree A Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357977 [TBL] [Abstract][Full Text] [Related]
15. Botulinum neurotoxin type A subtype 2 confers greater safety than subtype 1 in a rat Parkinson's disease model. Itakura M; Kohda T; Kubo T; Semi Y; Nishiyama K; Azuma YT; Nakajima H; Kozaki S; Takeuchi T J Vet Med Sci; 2014 Aug; 76(8):1189-93. PubMed ID: 24849052 [TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxin A subtype 2 reduces pathological behaviors more effectively than subtype 1 in a rat Parkinson's disease model. Itakura M; Kohda T; Kubo T; Semi Y; Azuma YT; Nakajima H; Kozaki S; Takeuchi T Biochem Biophys Res Commun; 2014 May; 447(2):311-4. PubMed ID: 24713302 [TBL] [Abstract][Full Text] [Related]
17. Current and potential urological applications of botulinum toxin A. Jiang YH; Liao CH; Kuo HC Nat Rev Urol; 2015 Sep; 12(9):519-33. PubMed ID: 26260879 [TBL] [Abstract][Full Text] [Related]
18. Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal. Jost WH Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33503872 [TBL] [Abstract][Full Text] [Related]
19. Botulinum Neurotoxin-A Injected Intrastriatally into Hemiparkinsonian Rats Improves the Initiation Time for Left and Right Forelimbs in Both Forehand and Backhand Directions. Antipova V; Holzmann C; Hawlitschka A; Wree A Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823527 [TBL] [Abstract][Full Text] [Related]
20. Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease. Bonsi P; Cuomo D; Picconi B; Sciamanna G; Tscherter A; Tolu M; Bernardi G; Calabresi P; Pisani A Amino Acids; 2007 Feb; 32(2):189-95. PubMed ID: 16715415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]